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ABSTRACT 
 
 
 The long interspersed nuclear element-1 (LINE-1 or L1) is a transposable element 
comprising approximately 17.5% of the human genome. Its transposition has been linked to a 
variety of genetic disorders, resulting from gene disruptions, nucleotide deletions, duplications, 
and general chromosomal instability. L1 ORF2 protein is toxic even without active transposition. 
L1 is not strongly expressed in most somatic cells, but is transcribed in some germ, embryonic 
stem, and cancer cell lines. Zinc finger proteins (ZNFs) bind nucleic acids, and this MQP project 
investigated two ZNF’s, 146 and 507, initially identified in our lab (unpublished data) as 
potential L1 ORF-2-binding proteins from Encode Chip-Seq data.  The functions of ZNF146 and 
ZNF507 functions are unknown.  In this project, a bioinformatics approach was used to identify 
potential binding sites on the L1 element for the two ZNFs, and the sites were verified 
biochemically using pull-down assays.  The binding sites for ZNFs 146 & 507 were found to be 
highly conserved across primate L1 subfamilies, with ZNF507 showing a specific period for loss 
in binding.  Fluorescence microscopy showed that both ZNF146 and ZNF507 are localized to the 
nucleus. Over-expression of either ZNF through plasmid based transfection was toxic to HeLa 
cells, and showed possible signs of cell phase arrest in HEK293 cells. Knockdown of either ZNF 
in HEK293 cells resulted in a morphology similar to senescence. Immunoprecipitation of flag-
tagged ZNF507 followed by mass spectroscopy identified arginine methyl transferase PRMT5 as 
a ZNF507-binding protein.  Future experiments will analyze transcriptome alterations in ZNF146 
and ZNF507 knockdown cells, and determine associated proteins for ZNF146. 
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BACKGROUND 
 
 
The Junk Genome 
 
It has been known since the completion of the human genome project that only a small 
portion of the human genome is comprised of protein-coding sequences.  The vast majority of 
the genome is non-protein-coding (non-coding) and had been relatively understudied for years as 
“junk DNA”(Palazzo and Gregory, 2014). Research regarding the importance of the non-coding 
regions of the genome has become more prevalent in recent years, in part due to large-scale 
efforts to identify functional regions in the human genome.  An example is the Encyclopedia of 
DNA Elements (ENCODE) project (Palazzo and Gregory, 2014), whose authors state that 
biochemical function can be assigned to an astounding 80% of the genome. Although the 
percentage is still highly debated, much research focuses on determining how much of the 
human genome is functionally significant at the organismal level (Nesbo, 2013). 
         The first use of the term “junk DNA” can be traced back to the 1960s, when researcher 
Susumu Ohno used the term to describe what are now known as pseudogenes (Ohno, 1972). The 
application of the term has since expanded to apply to any DNA sequence that does not play a 
functional role in development, physiology, or some other function at the organismal level 
(Palazzo and Gregory, 2014). This application of the term is central to the ongoing debates about 
the quality, or even existence, of “junk DNA” within humans and other organisms. But is any 
part of the genome really junk?  Does every sequence fulfill some function that simply has yet to 
be identified? 
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Non-Coding Genome Composition 
         Although the functions of non-coding portions of the genome are not well understood, the 
characteristics of these sequences are generally known. The non-coding genome makes up 
roughly 98% of the genome, and can generally be broken down into four major groups: LINES 
(21%), Introns (21%), SINES (13%), and Tandem Repeats (12%) (Figure 1) (Alexander et al., 
2010; Meisenberg and Simmons, 2017).  
 
 
 
 
 
 
 
 
Figure 1. Divisions of the Non-Coding Genome. Note this is only one proposed model, there are many 
others which account for the range in proportions of the various elements that shift with continuous research. 
Adapted from Principles of Medical Biochemistry, Figure 7.5. 
 
The groupings are very dynamic, and change from year to year, and source to source. 
One group is the conserved sequences (not shown in the figure), shared between humans and 
other mammals, which constitute about 5% of the genome. The conserved sequences are 
comprised mainly of long-noncoding RNAs (lncRNAs), theorized to represent about 0.4% of the 
genome, and sequences which are bound by transcription factors, representing about 8.5-12% of 
the genome (Palazzo and Gregory, 2014; Meisenberg and Simmons, 2017). Another group of 
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sequences are known as pseudogenes, genes in which one copy has been mutated such that it has 
lost its ability to encode a functional protein. Pseudogenes can also be produced when an RNA is 
reverse transcribed and then integrated into the genome. It is estimated that there are roughly 
12,600 to 19,700 pseudogenes within the human genome, comprising about 6% (Pei et al., 2012). 
Introns comprise a large portion of non-protein-coding regions, making up roughly 20-40% of 
the human genome, although this value is likely overestimated due to the fact that the introns 
often contain elements of the other groups like transposable elements, thereby inflating their 
contribution (Bulmer 1987; Gibbs, 2003; Palazzo and Gregory, 2014). 
A larger fraction, roughly two-thirds, of the genome consists of highly repetitive DNA.  
These regions are extremely varied among individuals of the same population, because the 
sequences can expand or contract through processes like unequal crossing over or replication 
slippage (Koning et al., 2011). Some highly repetitive sequences have been found to play a role 
in gene regulation, while other sequences play critical roles in chromosomal maintenance 
(Koning et al., 2011). The most heavily studied repetitive elements are transposable elements 
(TE). Transposable elements make up a large proportion of the non-coding DNA, and include 
various well-described retro-elements such as Short and Long Interspersed Nuclear Elements 
(SINEs and LINEs), endogenous retroviruses, and cut-and-paste DNA transposons (Rodic and 
Burns, 2013; Palazzo and Gregory, 2014). These elements in total make up roughly 45% of the 
human genome (Beck et al., 2011). While high in copy number, a vast majority of these elements 
are inactive in humans due to high degradation by mutations (Gregory, 2005). As a result of the 
degeneracy, estimates of the TE portion of the human genome widely vary, are thought to make 
up at least two-thirds of the genome (Gregory, 2005; Koning et al., 2011; Palazzo and Gregory, 
2014). While TE’s make a large contribution to the genome, their function is known for only a 
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few. After factoring in other sequence elements, such as unique elements which do not fall into 
any of the previous categories or tandem repeats and segmental duplications, it is thought that 
only 1-2% of the genome contains protein coding sequences (Alexander et al., 2010; Palazzo 
and Gregory, 2014; Meisenberg and Simmons, 2017). 
 
 
Long Interspersed Nuclear Element-1 (Line-1 or L1) 
 
The non-LTR long interspersed nuclear element 1 (LINE-1/L1) is a transposable element 
that comprises approximately 17.5% of the human genome (Beck et al., 2011 & 
repeatmasker.org). Due its nature as a transposable element, most L1 elements are 5’ truncated 
upon transposition and are therefore rendered inactive (Beck et al., 2011). Of the roughly 
950,000 fragments of L1 that exist in the genome, only roughly 150 copies remain intact and 
theoretically can move through transposition. Of that portion, it is estimated that only roughly 60 
copies are potentially active in the genome (Brouha et al., 2003; Bao et al., 2015). The generally 
conserved structure of L1 (Figure 2) is comprised of two open reading frames (ORF1 and 
ORF2), along with 3’ and 5’ UTRs.  
 
 
 
 
 
 
Figure 2.  Diagram of the L1 Structure and Domains. Abbreviations: C, cysteine-rich domain; CC, coiled 
coil; CTD, carboxyl-terminal domain; RRM, RNA recognition motif; EN, endonuclease; RT, reverse 
transcriptase; SVA, SINE-R/VNTR/Alu; UTR, untranslated region; AAA, poly(A) tail. Adapted from 
Gregory, 2005.  
 
Studies regarding the function of the two L1 open reading frames have speculated that 
ORF1 functions to produce a chaperone for other factors required for transposition (Martin, 
2006; Beck et al., 2011; Rodic and Burns, 2013). ORF2 on the other hand contains the elements 
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needed to perform transposition, including domains for both reverse transcriptase and 
endonuclease activity. Presence of ORF2 alone has been shown to induce cell senescence 
without the need for full L1 retrotransposition (Wallace et al, 2008).    In addition to L1 itself, the 
ORF2 is required for other repeat elements, like Alu and SVA, to transpose successfully (Beck et 
al., 2011; Rodic and Burns, 2013). Due the truncation of the 5’ end of the gene, the second open 
reading frame can exist as an independent fragment, where only the second open reading frame 
is inserted back in the genome. 3’ truncated fragments also exist by the same logic, although 
these are less numerous and less studied.  
 
L1 Retrotransposition 
 L1 sequences, although inactive in most somatic cells, are active in the germ line cells, 
embryonic stem cells, and some cancer lines (Rodic and Burns, 2013). Although the mechanism 
of retro-transposition is not fully understood, it can be inferred from the two key enzymes of the 
sequence. The first is integrase, an endonuclease that cleaves at the site of integration to generate 
a staggered break (Figure 3) (Alberts et al., 2002). The other enzymatic activity comes from the 
reverse transcriptase. 
 
 
 
 
 
Figure 3. L1 Retrotransposition and Life Cycle. Shown on the left is L1 inhibition which occurs within 
somatic cells. The mechanism of inhibition is currently unknown. Shown on right are cell lines in which L1 
expression is active (i.e. neoplastic, cancer, and germ cell lines) along with the theorized mechanism of 
retrotransposition. Adapted from Rodić & Burns, 2013 and Richardson, et al., 2015. 
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The first step of retro-transposition involves the transcription of genomic L1 into RNA, 
which is mediated by RNA polymerase II from an internal L1 promoter. Next, the RNA is 
translated into the two L1-encoded proteins: ORF1, an RNA-binding protein, and ORF2, a 
protein with reverse transcriptase and endonuclease activities. These proteins associate with the 
L1 transcript, and the resulting ribonucleoprotein (RNP) complexes then move to the nucleus. 
The third step is known as target-primed reverse transcription (TPRT). During TPRT, the ORF2 
protein cleaves the target DNA, often at a 5′-TTTTAA-3′ consensus sequence, and uses the 3′ 
hydroxyl group to prime the reverse transcription reaction (Beck et al., 2010; Richardson et al., 
2015). Because the L1 life cycle generates staggered DNA breaks at the target reintegration site, 
cell host proteins that mediate DNA repair are then likely responsible for integration of the L1 
sequence back into the genome (Richardson et al., 2015).  
 
 
Proposed L1 Functions 
 
         Several studies have examined the expression and function of L1 on a larger scale. It has 
been theorized that full-length L1 mRNA is expressed very little, if at all, in somatic tissues, with 
detection possible mainly in germ line cells (Ergun et al., 2004). However, other studies have 
noted that L1 expression may occur in both a normal human brain and other cell lines 
(Richardson et al., 2015). L1 has been shown to be responsible for many genetic disorders 
stemming transposition, including: gene disruption, nucleotide deletions, duplications, and 
general chromosomal instability through heterologous recombination (Beck et al., 2010). L1 may 
also play an important role in genomic functions ranging from regulation of gene expression to 
being influencing X-inactivation in females (Beck et al., 2011). The L1 reverse transcriptase may 
also have a role in the creation of processed pseudogenes. L1-associated DNA damage across a 
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wide spectrum of tissue samples has also suggested that L1 may function as an endogenous 
mutagen in somatic tissues (Richardson et al., 2015). Other studies have narrowed their focus on 
the expressional effects of individual open reading frames. ORF2 splice products have been 
found to lead to genetic damage, mirroring expression of the exogenous full-length L1 (Beck et 
al., 2011). Due to the truncated nature of ORF1 on the 5’ end, and a lack in regions of homology, 
the function of the ORF1 protein is much less understood. However, the ORF1 protein is known 
to be a nucleic acid chaperone that is required for transposition, and also is a high affinity RNA 
binding protein with L1 RNA, to form a ribonucleoprotein particle (Beck et al., 2011). 
 
L1 Evolution and Phylogeny 
         LINE-1 elements also have a rich and dynamic evolutionary history, extending back 
more than a hundred million years, characterized by the rise, fall and replacement of subfamilies 
(Figure 4) (Khan et al., 2006; Waters et al., 2008; Cordaux and Batzer, 2009; Boissinot and 
Sookdeo, 2016). Most of the data concerning LINE-1 biology and evolution are derived from the 
human and mouse genomes, which are often assumed to hold true for all placentals and most 
eutherian. This is due to the fact that the mode of L1 evolution has been conserved since the 
origin of mammals (Boissinot and Sookdeo, 2016). In mammals, only the most recently evolved 
group of elements is ususally active at one time, so that a single family of progenitors is usually 
producing novel insertions. In the long term, this will lead to a ladder-shaped phylogeny, 
stemming from the replacement of one family by a younger one in a cycle (Boissinot and 
Sookdeo, 2016). This mode of evolution is consistent with the arms race belief, covered in 
further detail later. Reptiles and fish on the other hand have several highly divergent families 
concurrently active in the same genome. These active families have coexisted for an extended 
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period of time, and their divergence may pre-date the origin of vertebrates (Khan et al., 2006; 
Boissinot and Sookdeo, 2016).  
 
Figure 4. Phylogenetic Evolution of L1 and Naming Conventions. Shown is the 
evolutionary progression from ancestral L1 subfamilies still present in the genome to 
modern human L1 (PA1), along with the naming conventions of the 3’-UTR and 5’-
ORF2 sequences. Made using data from Smit et al., 1995 and Khan et al., 2006. 
 
The naming conventions for the L1 subfamilies are based on 5’ truncated or 3’ ORF2 
regions (Smit et al., 1995).  The 3’ ORF2-derived sequences are labeled as M or P, M for 
mammalian, or P for primate.  Subfamily specifications are shown by a following letter ranging 
from A to E, A being the youngest, and so on. The subfamilies are then arranged by age in 
reverse chronological order, with the most recent family numbered as 1, and older families 
increasing in age until the sequence reaches the point of divergence from a previous subfamily, 
like primates divergence from mammalian (Figure 4). 5’ truncated sequences are named in a 
similar manner, M for mammalian or P for primate. However subfamily specification is broader, 
only containing the reverse chronological numbering. The 3’ and 5’ families can generally be 
grouped together in terms of age and the evolutionary pathway which leads to the current human 
L1 subfamily (Figure 4). Furthermore, it is also theorized that primate L1 diverged from modern 
mammalian L1 at roughly the MA6 subfamily (Smit et al., 1995; Khan et al., 2006; Boissinot 
and Sookdeo, 2016).  
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L1 Repression and Evolutionary Pressure 
 
 
Although L1 expression is known to be toxic and must be repressed in somatic tissues, 
the exact mechanism of inhibition is also not fully understood at this time. Several reports have 
identified factors which inhibit L1 expression in some cases, but these do not explain long-term 
repression of endogenous L1 (Rodic and Burns, 2013; Walter et al., 2016; Guler et al., 2017; 
Sokolowski et al., 2017). Others report the simultaneous suppression of Alu elements along with 
L1 elements. A common thread between most findings is that they all share similar modes of 
repression, either DNA methylation or histone modification, to suppress active L1 sequences 
(Rodic and Burns, 2013; Paco et al., 2015; Guler et al., 2017). However, what is clear from the 
phylogeny and evolution of L1 (previously discussed) is that there has been a pattern of L1 
reactivation in which L1 bypasses repression, becomes active, and once again must be repressed. 
This theory is believed to be a type of arms race between the host, which represses L1 
transposition, and L1, which evolves to bypass repression, and has gone on throughout the 
evolution of L1. L1 elements are also known as selfish elements, that persist over time due to 
their replicative advantage over the host genome (Paco et al., 2015).  
This is not to say that L1 expression is without benefits.  As previously stated, L1 
sequences play an important role in gene expression and other activities. In a broad sense, L1 
sequences can arguably be one of the most significant and dynamic forces operating on the 
mammalian genome, having potentially significant impact of the genesis of genetic diseases like 
cancer and genome evolution (Cordaux and Batzer, 2009; Pei et al., 2012; Boissinot and 
Sookdeo, 2016). L1 retro-transposition can cause various effects in the genome like 
rearrangement of gene promoters, enhancers, and even exons by the transcription of flanking  
non-L1 sequences (Cordaux and Batzer, 2009). Genes generally are affected when they are a 
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target site for insertion, and there is evidence to say this can also happen without interfering in 
the coding region (Cordaux and Batzer, 2009).  L1 insertion into the UTR of a gene can affect 
the regulation of its transcription and translation (Boissinot and Sookdeo, 2016). Even outside of 
the transposition itself, homologous sequences are created in non-homologous regions, providing 
a platform for recombination on misaligned chromosomes, potentially resulting in chromosomal 
rearrangements (Cordaux and Batzer, 2009; Boissinot and Sookdeo, 2016). If L1 was repressed 
with no possibility of escape, it would not have the same potential to drive evolution.  
 
Zinc Finger Proteins (ZNFs) 
 Zinc finger proteins (ZNFs) are a widely diverse class of proteins which bind to specific 
motifs within their target structures, either nucleic acid or amino acid sequences. Although they 
are diverse, all zinc finger proteins generally share a common feature, a coordination with at 
least one zinc ion (Krishna et al., 2003; Laity et al., 2001). The zinc ion acts to stabilize the 
integration of the protein itself and therefore is not directly involved in target binding. The 
fingers are secondary structures held together by the zinc ion. These zinc fingers contain 
domains that typically serve to interact with other elements, such as binding with DNA, RNA, 
proteins, or other small molecules. The specific association of these proteins with the zinc ion 
classifies them as zinc finger domains. Many types of zinc finger structures form in a predictable 
manner, based predominately on specific sequence features, and these features have been used to 
identify many new ZNFs (Krishna et al., 2003). 
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Classes of ZNF-Binding Proteins 
 Zinc finger proteins are most often classified by the type of fold group of their zinc 
fingers. Fold group types include a C2H2-like finger, gag knuckle, treble clef finger, zinc ribbon, 
Zn2/Cys6-like finger, Taz2 domain-like, short zinc binding loops, or metallothionein domains 
(Krishna et al., 2003). Furthermore, the type of interaction the finger has can often be linked to 
its fold group (Krishna et al., 2003). Each type of fold group binds zinc and associated proteins 
through different features within the protein sequence. For example, the treble clef motif consists 
of one β-hairpin at the N-terminus and one α-helix at the C-terminus, that together contribute two 
zinc-binding domains. The first two ligand-binding domains derive from the zinc knuckle (a turn 
caused by interactions with two zinc ions), and the other two ligand-binding domains are donated 
by the N-terminal turn of the helix. On the other hand, gag knuckle fingers are composed of two 
short β-strands connected by a turn, one zinc knuckle, followed by a short helix or a loop. The 
size of the fingers of these two fold groups also differs, as do the sizes of any of the fold groups 
(Krishna et al., 2003). These differences in size and structure of the zinc fingers allow each of the 
different classes to bind different targets and specific binding motifs by methods beyond just the 
sequence of the binding region of the finger itself.  These differences allow for zinc finger 
proteins to specifically bind to not only DNA and RNA sequences, but also amino acid 
sequences of other proteins, as seen with some zinc ribbon domains (Krishna et al., 2003). Some 
zinc finger domains can even bind specifically to a molecule outside of the central dogma, such 
as to a phosphate residue.  An example is the Phosphatidylinositol-3-phosphate-binding domain, 
a subset of the treble cleft fold group (Krishna et al., 2003).  
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Cys2His2 (C2H2) Zinc Finger Structures and DNA Binding 
One of the most abundant zinc fingers in the eukaryotic genome is the Cys2His2 zinc 
finger (C2H2).  This finger type is 20-30 aa long, and often binds to DNA (Krishna et al., 2003). 
This mode of DNA binding is similar among nearly all DNA-binding zinc fingers. Furthermore, 
for C2H2 fingers, the finger-to-DNA binding occurs in a very conserved manner (Krishna et al., 
2003; Persikov et al., 2008). Nucleic acid-binding C2H2 zinc fingers bind to the major groove of 
DNA through the N-terminus of the α-helix. C2H2 zinc fingers also contain three conserved 
hydrophobic amino acids at positions -12, -3 and +4, in addition to the two conserved cysteines 
and histidines.  These seven amino acid residues are necessary and sufficient to fold peptides 
properly, as shown by using a designed-synthetic peptide to create a C2H2 zinc finger (Luchi, 
2001).  
Recognition of specific DNA sequences along with increased stability and binding 
strength is created through tandem C2H2 zinc fingers.  Tandem zinc fingers allow for 
cooperative binding of the α-helices of several C2H2 zinc fingers arranged in tandem to longer 
and more complex DNA sequences. While a single finger usually specifies binding to three 
nucleotides, tandem zinc fingers allow for longer binding sequences, which increases the 
specificity and stability of the binding (Luchi, 2001) (Figure 5).  
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Figure 5. C2H2 Zinc Finger Motif Structure and Binding. A) The tertiary structure within a zinc finger 
protein which yields as C2H2 zinc finger. B) The conserved amino acid sequence pattern that determines 
the binding region of the zinc finger, this pattern defines C2H2 zinc fingers, and can be predicted from an 
amino acid sequence. C) Overview of a zinc finger domain which allows for DNA binding specificity. 
Adapted from Von Nickisch-Rosenegk, 2005 and Heil & Noor, 2012.   
 
The C2H2 zinc finger distribution within a protein can also play a role in DNA binding. 
Based on the distribution of zinc finger domains, ZNFs are divided into three classes: triple, 
multiple-adjacent, and separated-pairs (Figure 6) (Luchi, 2001). This classification is useful for 
predicting binding activity. Triplet and multiple-adjacent types bind to DNA at consecutive 
fingers.  However, for separate-pair ZNFs, a minimum of two consecutive zinc fingers are 
required for DNA-binding (Luchi, 2001). The link between pairs is also flexible and allows for 
separate pairs to interact and bind DNA. This is not however universal, as separated-pairs of zinc 
fingers can interact with DNA at different contact points, and they do not necessarily interact 
directly with each other (Luchi, 2001).  
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Figure 6. C2H2 Zinc Finger Classes. C2H2 zinc fingers are divided into three classes based upon the type 
of zinc finger distribution. Triplet fingers (top row) contain three consecutive fingers (yellow), while 
multiple-adjacent types (middle row) contain many consecutive fingers. Separated-pair types contain pairs 
of zinc fingers separated by a long stretch of amino acids. Adapted from Luchi, 2001. 
 
 
 
C2H2 fingers are also among the most common DNA-binding motifs found in eukaryotic 
transcription factors (Krishna et al., 2003). Finger predictions can be made from an amino acid 
sequence without the need for crystal structure analysis (Persikov et al., 2008). Finger 
predictions are generally made by detecting cysteines spaced four residues apart at the amino 
terminal, and histidine residues with the same spacing at the carboxy terminal (Krishna et al., 
2003, Persikov et al., 2008a, b). Binding residues are usually deduced by looking only within the 
finger predictions, although this approach is tentative without the protein crystal structure.  
 
 
Zinc Finger Protein 146 (ZNF146) 
 
 
 This project investigated two ZNF’s: 146 and 507.  These two ZNFs were identified in 
our lab (unpublished data) from Encode Chip-Seq data as potential LINE-1-binding proteins.  
Zinc finger protein 146 (ZNF146), also referred to as “only zinc fingers” (OZF) (Chalony et al., 
1994), is a zinc finger protein composed almost entirely of zinc finger domains (Persikov et al., 
2008b, Heil and Noor, 2012, Zerbino et al., 2018). The gene encoding the 292 amino acid protein 
is located on chromosome 19, band 13.12 (Zerbino et al., 2018). The sequence contains ten 
equally spaced C2H2 zinc finger domains that constitute most of the protein (Figure 7).  
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Figure 7. Diagram of the ZNF146 & ZNF507 Zinc Finger Structures. Shown are the 
location of the zinc fingers (yellow) on proteins ZNF146 and ZNF507, which were 
studied in this MQP project. 
 
However, very little is known about ZNF146 function. ZNF146 over-expression has been linked 
to certain cancers, like pancreatic and colorectal cancer (Ferbus et al., 1999; Ferbus et al., 2003). 
Targeted expression of ZNF146 has also been shown to be associated with impaired mammary 
development in mice (Xie, 1997). ZNF146 has also been found to interact with telomeric protein 
hRap1 in colon carcinoma (Antoine et al., 2005). Apart from these studies, little else is known 
about ZNF146 at this time. 
 
Zinc Finger Protein 507 (ZNF507) 
 Similar to ZNF146, not much is known about zinc finger protein 507 (ZNF507). This 
protein is much larger than ZNF146, with a length of 957 amino acids.  The gene is located on 
chromosome 19, band 13.11 (Zerbino et al., 2018).  This protein contains only nine zinc fingers, 
three of which are grouped at the amino terminus, and the other 6 are grouped at the carboxy 
terminus (Figure 7) (Persikov et al., 2008b; Zerbino et al., 2018).  Two recent genomic findings 
have been made in regards to ZNF507 function. The first study revealed a locus that includes 
ZNF507 and confers risk to neurodevelopmental disorders across diagnostic boundaries 
(Talkowski et al., 2012). The second study found ZNF507 to be one of many genes with 
increased expression linked to schizophrenia (Curtis, 2015).  
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ZNF-Binding Proteins 
 Zinc finger proteins have the ability to associate with other proteins. Many of the 
documented interactions with ZNF proteins occur with proteins that affect gene regulation 
(Schneider et al., 1997; Schultz et al., 2002; Sun et al., 1996).  Examples include binding to 
regulatory proteins like KAP-1 (a H3K9 methyl-transferase) and Myc (Schneider et al., 1997; 
Schultz et al., 2002). In these cases, the ZNF proteins act as a guide for the associated proteins to 
allow for specific DNA sequence targeting by interacting with proteins that would otherwise be 
unable to bind DNA at that location, or are unable to bind DNA at all by themselves (Sun et al., 
1996). The type of gene regulation affected depends on the associated protein, the ZNF mostly 
acts as a guide to the DNA. For example, the ZNF interaction with KAP-1 leads to gene 
repression, while the interaction with Myc leads to gene activation (Schneider et al., 1997; 
Schultz et al., 2002).  ZNFs have also been found to interact with other ZNFs.  This interaction 
can occur via Krüppel-type (KRAB) domains. KRAB domains are transcriptional repressors 
found within some ZNF proteins (Schneider et al., 1997; Schultz et al., 2002; Sun et al., 1996). 
Alternatively, ZNFs can interact with other ZNFs via non-KRAB domains.  KRAB domain-
containing ZNFs are of high interest for study because they themselves can directly regulate gene 
expression.  
 
Project’s Relation to Ongoing Research in the Lawrence Lab 
 This study of the repetitive LINE-1 element and its potential binding proteins is part of a 
larger project of interest to the UMMS Lawrence lab concerning chromosomal organization and 
substructure. Similar to the cytoplasmic cytoskeleton, the nucleus also has a skeleton or scaffold.  
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This nuclear skeleton is composed of nuclear laminins, non-coding RNAs, and protein 
complexes which help organize and stabilize the DNA in the nucleus. LINE-1 elements, due to 
their highly repetitive, conserved, and dispersed nature across a majority of the genome, have the 
potential to play role in this structure. Nuclear scaffold structure is currently a topic of interest to 
our lab’s postdoctoral fellow Kevin Creamer, whose work analyzes the means by which the 
DNA is organized and positioned within the nucleus. He theorizes that non-coding RNA’s 
comprise a major portion of this nuclear skeleton, and his work aims to verify and characterize 
this structure. Since L1 elements are so abundant in the nucleus, they may play a role in genome 
organization. 
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PROJECT PURPOSE 
 
 The long interspersed nuclear element-1 (LINE-1 or L1) is a transposable element 
comprising approximately 17% of the human genome. Due to its transposition, L1 has been 
shown to be responsible for many genetic disorders resulting from gene disruptions, nucleotide 
deletions, duplications, and general chromosomal instability. L1 is not strongly expressed in 
most somatic cells, but is transcribed in germ line cells, embryonic stem cells, and some cancer 
cells. Zinc finger proteins (ZNFs) bind nucleic acids, and this MQP project investigated two 
ZNF’s that bind L1 DNA: ZNF146 and ZNF507.  These ZNFs were initially identified in our lab 
(unpublished data) from Encode Chip-Seq data as potential L1-binding proteins.  The functions 
of ZNFs 146 and 507 are unknown, but ZNF146 is over-expressed in pancreatic and colorectal 
cancers, and is associated with impaired mammary development in mice, while 507 is associated 
with a locus over-expressed in neurodevelopmental disorders.  In this project, a bioinformatics 
approach will be used to identify potential binding sites on the L1 DNA element for the two ZNF 
proteins, and if present, to determine their potential conservation throughout evolution.  The 
binding sites will also be verified biochemically using pull-down assays.  The cellular location of 
ZNF146 and ZNF507 will be determined using flag-tagged proteins and fluorescence 
microscopy.  ZNF-binding proteins will be identified using immunoprecipitation assays with 
flag-tagged ZNFs.   
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METHODS 
Cell Culture 
 Cell lines used during this project included HeLa (human cervical carcinoma cell line) 
(ATCC), HEK293 (human embryonic kidney cell line) (ATCC), and human TIG-1 fibroblast cell 
lines (ATCC). Cultures were fed using 10mL of DMEM+10%FBS+1XP/S, and incubated in T-
75 flasks at 37C until confluent. Cultures were split for subculture after aspiration of the DMEM 
media and a wash with 5mL of Hanks culture medium. Cells were then treated with 2mL of 1X 
TrypLE Express (ThermoFisher) for five minutes at room temperature to dislodge the cells, then 
the cells were re-suspended in an additional 2mL of DMEM+FBS+PS. 1mL of this cell 
suspension was placed into 10mL of fresh DMEM+FBS+PS in a new T-75 flask, and the flask 
was incubated until confluent, and then either sub-cultured or used for an experiment. 
 
Coverslip Culture and Fixation 
 In order to visualize cells under the microscope, cells were cultured and fixed onto glass 
coverslips. Cell suspensions were taken after testing, and cultured on coverslips placed into wells 
of a 6-well plate. 500uL of cell suspension was cultured with 1.5mL of fresh medium for at least 
24 hours prior to fixation at 37C. Following culture, the medium was aspirated from the wells, 
and the coverslips were then washed twice using hanks balanced salt solution (HBS). For 
standard fixation, cells were moved into coplin jars on ice containing CSK buffer long enough to 
rinse. Coverslips were then moved into coplin jars, also on ice, containing a mixture of 9mL 
CSK, 0.5mL 10X trition, and 0.5mL VRC for 4 minutes. Cells were then fixed to the coverslips 
by placing them in a third coplin jar containing 4% paraformaldehyde at room temperature, for 
10 minutes. Coverslips were then stored in 70% ethanol within a new 6-well plate at 4C until 
imaged.  
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Immunofluorence Assay (IFA) 
 The cellular locations of plasmid-expressed Flag-tagged ZNFs 146 and 507 were 
determined by an immunofluorescence microscopy assay (IFA) using a Flag antibody. IFA 
microscopy was also used to visualize Ki67, laminin-B, and tubulin.  The following antibodies 
were used: anti-mouse Flag M2 (Sigma), anti-rabbit Ki67 (Abcam), anti-mouse laminin B (Santa 
Cruz), and anti-rabbit tubulin (Lab Vision). Coverslips stored at 4C were moved into a coplin jar 
containing 1X PBS for at least 10 minutes to rehydrate the cells. During this time the primary 
antibody stain mixtures were prepared using 500uL of 1X PBS/1% BSA with the desired 
concentration of antibody for the target diluted within with 1uL of RNase inhibitor added.  The 
coverslips were placed cell side down on top of 70uL of the desired primary antibody stain on 
parafilm placed on a glass plate. This was then sealed and incubated in a humidified chamber for 
1 hour. Following incubation, coverslips were washed in coplin jars containing 1X PBS, then 1X 
PBS+0.1% triton, and finally 1X PBS, respectively for 10 minutes each on a shaker. Coverslips 
were then stained with the secondary antibody, 1:500 dilutions of either Alexa or Dylight 488 or 
594, that recognized the respective animal host of the primary stain, in the same manner as the 
primary stain, except covered in tinfoil to keep dark. The coverslips were washed again as 
described for the primary antibodies, except they were covered to keep the coplin jar in the dark 
on the shaker. Coverslips were then stained using a DAPI solution for 30 seconds and then 
washed in 1X PBS. Coverslips were then mounted on microscope slides using one drop of 
Vectashield mounting medium and sealed using nail polish. Slides were stored at 4C when not 
being imaged. Coverslips containing cells were visualized under 100X magnification. 
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Protein Expression Alterations Through Transfections  
 In order to examine the effects of differential expression of ZNFs 146 and 507, 
expression plasmids for each ZNF were introduced into cells by transfection. Flag-tagged 
expression plasmids were used for over-expressions, and shRNA expressing plasmids were used 
for knock downs.   Cells were dislodged from culture flasks when they were about 90% 
confluent. Approximately 10 million cells per T75 flask were washed with Hanks culture 
medium and were then dislodged through treatment with 2mL of 1X TrypLE for five minutes at 
room temperature. 2.5mL of DMEM+10%FBS without antibiotics was then used to deactivate 
the TrypLE and to re-suspend the cells. For continued culture, 500uL of this suspension was 
moved into a new T75 flask with 10mL of DMEM+FBS with antibiotics. 2mL of the remaining 
volume of cell suspension was then spun down for three minutes at roughly 1,000rpm. The 
medium was aspirated from the cell pellet which was then washed and spun down twice in 5mL 
of 1X PBS under the same centrifugation parameters. The cell pellet was then re-suspended in 
4mL of MEM without antibiotics, and 0.5mL of the suspension and 0.5mL of MEM was added 
to coverslips which were placed into individual wells of a 6-well plate. 
 Next, the plasmid solutions were prepared for transfection. 10ug of each flag-tagged 
over-expression plasmid, or an empty vector control, were added to 500uL of opti-MEM. For 
each plasmid mixture, 12uL of lipofectamine 2000 was added to 500uL of opti-MEM. After four 
minutes the lipofectamine mixtures were added to the plasmid mixes to undergo lipofection for 
twelve minutes. 500uL was added two one well plate for each plasmid mixture, two sets for each 
plasmid. After the addition of all plasmid mixtures, an additional 1mL of MEM was added to the 
wells, and the cultures were mixed through shaking of the well plate. Cells were allowed to 
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transfect for 6 hours at 37C, after which the medium was replaced with fresh MEM. The cells 
were then cultured for 48 hours at 37C prior to fixation on the cover slips. 
 
Nuclear Extractions 
 In order to isolate or quantitate the ZNFs, nuclear extracts were prepared from transfected 
cell cultures. Using at least 12, 10-cm dishes of 90% confluent cultures, cell pellets were 
obtained through treatment with 2mL TrypLE, re-suspended in 2mL of MEM for each dish, 
pooled, and then centrifuged at 1,000 rpm for 3 minutes. Cell pellets were then washed and spun 
down in 50mL of 1X PBS twice more under the same parameters.  
To lyse the cell pellets, two buffers were prepared and kept on ice. Buffer A was made 
using 10mM HEPES pH 7.5, 1.5mM MgCl2, 10mM NaCl, 1mM DTT, and 1 protease inhibitor 
cocktail tablet. Buffer B was made with 20mM HEPES, 500mM NaCl, 1.5mM MgCl2, 25% 
glycerol, and 1 protease inhibitor tablet. Once washed, the cell pellets were re-suspended in 4mL 
of Buffer A, transferred into 4 Eppendorf tubes, and spun down for 4 minutes at 3,000rpm in a 
cold environment (20C). The supernatant was removed, and each pellet was re-suspended in 
1mL of Buffer A supplemented to 0.075% NP-40 (37.5ul 10%/5ml) and incubated on ice for 5 
minutes. The cell suspension was then spun down for 3 minutes at 3,000rpm at 20C once again, 
and the supernatant was removed. The pellets were then washed once with 1mL Buffer A, by 
thoroughly re-suspending and again spinning to pellet the nuclei. The nuclear extract was then 
made by thoroughly re-suspending the cell pellet in 1mL Buffer B. The four tubes were then 
combined into a single 15ml conical tube, and vortexed for 5 seconds at max speed and placed 
on ice 15 minutes. The samples were then vortexed once more before spinning 12,000rpm for 5 
minutes at 4C to remove cell debris. The supernatants of identical samples were combined into a 
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new 15ml conical tube. The nuclear extract was then divided into into aliquots and frozen on dry 
ice before storing in -80C for later use. 
 
Immunoprecipitations  
 In order to verify the presence of and to purify the specific ZNF proteins within the 
nuclear extract, target proteins were isolated from the samples using immune-precipitation. Once 
thawed 20uL of extract was taken and placed on ice for use as an input. Next, 400uL of extract 
was taken from the sample and added to 1mL of IP dilution buffer for an extract from 4x10cm 
plates and placed on ice. The extracts were pre-cleared with IgG beads, and then incubated with 
anti-flag conjugated magnetic beads overnight at 4C on a rotator. The beads were then capture, 
washed with 500uL of TBS+0.1% Triton for 5 minutes on a rotator, and recaptured for a total of 
three washes. After the second wash in the cycle the beads were transferred into a new tube. The 
same cycle of washes were then used to wash the beads in just TBS buffer. Following the 
washes, the beads were then incubated with 50uL of 3X flag peptide for 30 minutes at 4C on the 
rotator. Beads were then capture and elutions were taken. The beads were then washed and 
incubated with flag peptide for a total of three elutions. Elutes were pooled following the final 
elution. The elutions were then treated with trichloroacetic acid (TCA) and incubated for 10 
minutes at 4C. Samples were then spun down at 14,000rpm, also at 4C, with the supernatant 
being removed leaving only the protein pellet. The pellets were washed with 500uL of cold 95% 
acetone and spun down again. The process was done for a total of two acetone washes. 
Following the washes 20uL of 2X sample buffer was added to each sample, each sample was 
mixed with minute traces of NaOH, and each sample was boiled for 10 minutes on the 80C heat 
block.  
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ZNF Biotinylated Oligo Pulldown Assay 
 In order to test whether the predicted LINE-1 DNA ZNF-binding motifs are functional, 
nuclear extracts containing ZNFs were used in biotinylated DNA pulldown assays. First, biotin-
labeled double stranded (ds) DNA oligos containing the predicted LINE-1 binding motif (shown 
below) were purchased commercially (IDT).  Then, streptavidin beads were bound to the DNA 
oligos. To prepare the beads for the assay, the lyophilized oligos were dissolved to a 
concentration of 1mM (1 nmol/uL) in water. The oligos were then diluted to 20uM in water. 100 
uL of complementary oligos with 100uL NEB buffer 2 and 700uL water were then added to the 
mix to total 1mL. These mixtures and 200uL of salmon sperm DNA were incubated at 95C for 4 
minutes, then allowed to cool to room temperature. The oligo-bound beads were now primed to 
bind proteins in the extracts. 
For each reaction, 15uL of magnetic beads was added to 100uL of Wash Buffer A, made 
with 20mM Tris pH 7.5, 150mM NaCl, 1.5mM MgCl2, 10% glycerol, and optionally 10nM Zinc 
Acetate. The beads were captured on a magnet and re-suspended in 250ul/reaction in Buffer A. 
The beads were captured, washed, and recaptured a total of three times. After the third capture, 
the beads were re-suspended in 150uL of Buffer A per sample. 100uL of this suspension was 
used for binding to oligo, and 50uL was used for pre-clearing.  
For the beads used for oligo binding, 25uL of annealed biotin-dsDNA and 2.5uL of BSA 
(20mg/mL) were added to o 100uL of Buffer A, and this was added to the 100uL suspensions. 
This mixture was incubated for 30 minutes on the shaker and flicked every couple of minutes. 
The beads were than captured and re-suspended in 500uL of Buffer A, and recaptured for a total 
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of three washes. After the final wash, the beads were re-suspended in 20uL of Buffer A per 
sample.  
 Next, the pre-clearing samples were prepared to capture DNA/protein complexes. For 
each sample tested, a reaction mix was made containing 150uL of 2X dilution buffer, 28uL of 
water, 15uL of 20X protease inhibitors, 2uL BSA (20mg/mL), 2uL of annealed salmon sperm, 
100uL of nuclear extract, and the 50uL sample of washed beads (without biotin-dsDNA 
annealed). The 2X dilution buffer consisted of 40mM Tris pH 7.5 (2ml 1M/50ml), 20% glycerol 
(10ml/50ml), 0.1% NP-40 (0.5ml 10%/50ml), 2mM MgCl2 (100ul/50ml), and optionally 10nM 
Zinc Acetate. The reaction mixtures were incubated for 15 minutes on a shaker at room 
temperature, and were inverted every few minutes. The beads were then captured and the 
supernatant was moved into a new tube for each sample. 20uL of annealed beads in Buffer A 
was then added to the supernatant and incubated for 30 minutes on a shaker at room temperature, 
again flicking every few minutes. The beads were then captured and washed once in 500uL of 
Buffer A, capturing again immediately after suspension. The beads were then washed again with 
500uL of Buffer A, but were incubated for 5 minutes on the shaker before capture. The beads 
were then washed in 500uL of wash buffer B under the same parameters as the previous wash. 
Buffer B consisted of 10mM Tris pH 7.5, 75nM NaCl, 1.5mM MgCl2, 10% glycerol, and 
optionally 10nM Zinc Acetate. Finally the beads were washed one final time with 500uL Buffer 
B, then immediately re-suspended, inverted, and recaptured. The beads were then eluted with 
35uL of 1X Laemmli sample buffer with BME added. These samples were placed in the 80C 
heating block for 15 minutes and then spun down for 1 minute at 1,000rpm. The supernatant was 
then transferred to a new tube for each sample and stored at -80C until analyzed by SDS-PAGE.  
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Predicted LINE-1 ZnF146 binding motif- TGG AAT ACT ATG CAG CCA TAA AAA AGG 
ATG AG 
Forward strand consensus- CATATACACCATGGAATACTATGCAGCCATAAAAAATGATGAGTT 
CATATCCTTTGTAGG 
Complement- CCTACAAAGGATATGAACTCATCATTTTTTATGGCTGCATAGTATTCCATGGTGTATATG 
Reverse strand consensus- CCTACAAAGGATATGAACTCATCATTTTTTATGGCTGC ATAGTATTCCATGGTGTA 
Complement- ACACCATGGAATACTATGCAGCCATAAAAAATGATGAGTTCATATCCTTTGTAGG 
  
Predicted LINE-1 ZnF507 binding motif- CAA ATT CAA ATT TAA ACA TAA TAA TAT TA 
Forward strand consensus- CATCATAATGACAGGATCAAATTCACACATAACAATATTAACTTTAAATATAAATGGACT 
Complement- AGTCCATTTATATTTAAAGTTAATATTGTTATGTGTGAATTTGATCCTGTCATTATGATG 
Reverse strand consensus- AGTCCATTTATATTTAAAGTTATATTGTTATGTGTGAATTTGATCCTGTCATTAT 
Complement- ATAATGACAGGATCAAATTCACACATAACAATATTAACTTTAAATATAAATGGACT 
 
 
Quantitation of Proteins by BCA assay  
 Protein concentrations for samples collected from protein purifications and nuclear 
extracts were quantified using a Pierce BCA assay kit. Protein absorbance levels were measured 
and compared to a series of BSA dilution standards. 
 
Western Blots 
 The levels of ZNF proteins 146 and 507 were determined by Western blots.  Protein 
samples were loaded onto pre-cast 26-well PAGE gels (4-20% gradient) (Criterion TGX). 
Samples were electrophoresed for 150 volts for roughly an hour, until the bromphenol blue 
bands had reached the bottom of the gel. The separated proteins were transferred onto DUDF 
membrane film by transblotting at 100amp electrophoresis for 2 hours using transfer buffer (10% 
methanol, 0.04% SDS). The membrane was then blocked by incubating with PBS+0.05% 
Tween+5% blotting-grade blocker for 1 hour. The membrane was than washed in PBS+0.05% 
Tween (PBST), and stored in fresh PBST at 4C.  
 The following primary antibodies were used: anti-rabbit ZNF146 (Novus), anti-rabbit 
ZNF507 (Thermo), anti-mouse Flag M2 (sigma).  The membranes were trimmed around the 
areas of interest, and then incubated in primary antibody diluted 1:400 in PBST overnight at 4C 
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on a shaker. The membranes were then washed three times in PBST for 5 minutes each, and then 
treated with HRP conjugated secondary antibody. The following antibodies were used; anti-
mouse and ant-rabbit HRP (Abcam). The secondary antibody (for the specific animal of the 
primary) was diluted 1:5000 in 10mL of PBST+3% blotting-grade blocker. The membrane was 
incubated with the secondary antibody on the shaker for 1 hour, rinsed in PBST, and then 
washed three times in PBST.  Washed membranes were treated with the buffers (Pierce ECL 
reagents A+B) of the protein imaging to stimulate chemiluminescece, and then imaged under 
high sensitivity parameters at increasing exposure times until the bands were sufficiently 
exposed. After imaging, the membranes were rinsed and stored in fresh PBST at 4C.  
 
Mass-Spec Sample Prep 
 In order to detect other proteins interacting with the ZNFs, Flag-tagged ZNFs over-
expressed in transfected cells were immuno-precipitated from cell lysates.  The IP extracts were 
then electrophoresed on a gel, and stained with coomassie blue overnight to visualize the protein 
contents. The gel was then de-stained, and the lanes of interest were cut out and sent to the Mass 
Spectrometry Facility within UMass Medical School for analysis. 
 
Zinc Finger Predictions 
 LINE-1 DNA sequences predicted to bind ZNFs 146 and 507 were determined using 
Princeton servers (http://compbio.cs.princeton.edu/zf/). Amino acid sequences for the ZNF 
proteins were obtained from the Uniprot Database and used as input for the server to generate 
predicted zinc finger sequences and their associated DNA-binding domains. The Princeton 
serves were also used to predict whether the predicted zinc fingers for the two proteins showed 
significant binding specificity to a 40nt region around the predicted binding motifs. 
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DNA and Protein Sequence Alignments 
  LINE-1 DNA sequence alignments were obtained through Clustal-Omega alignments of 
L1 subfamily sequences from the dfam and repbase databases (http://www.dfam.org/ & 
http://www.girinst.org/repbase/). These alignments were then imported into Jalview 
(http://www.jalview.org/) to generate conservation scores of the tentative binding region within 
the alignment. This process was performed to generate L1 alignments and determine the 
conservation of sequences for the binding region of each ZNF protein across several species.  
 Alignments of the amino acid sequences for the zinc fingers of ZNF 146 and 507 were 
obtained in the same manner using amino acid sequences found on Uniprot, and aligning the 
sequences using Clustal-Omega. These alignments were imported into Jalview to generate 
conservation scores. Phylogenetic trees were generated through importing the alignments into 
wasabi (http://wasabiapp.org/).  
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RESULTS 
 
 
 The retro-transposition of L1 elements has been found to result in a variety of genetic 
disorders, resulting from the induced gene disruptions, nucleotide deletions, duplications, and 
general chromosomal instability. Furthermore, the expression of L1 ORF2 itself is toxic and can 
induce senescence. Thus, the cellular repression of L1 transposition or expression is important, 
yet the understanding of the proteins involved, and mechanisms that contribute to, L1 repression 
are incomplete.  Zinc finger proteins (ZNFs) bind both DNA sites and other regulatory proteins 
that affect gene expression, so this MQP sought to identify ZNFs that bind L1, and that could 
regulate L1 expression. 
 
Identification of Potential L1-Binding ZNFs 
 
 We began by examining the ENCODE database for ChIP enrichment peaks of various 
zinc finger proteins against repetitive elements.  The data (Figure 8) showed that ZNF146 and 
ZNF507 were strongly and uniquely enriched on L1 DNA relative to 153 other ZNF protein 
scrambled background peaks. Compared to the enrichment levels of 153 other ZNFs, ZNF146 
had 12.1-fold enrichment, while ZNF507 had 7.6-fold enrichment for L1 elements. Both ZNFs 
had notably stronger enrichment than any other ZNF on L1. 
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Figure 8. ChIP Enrichment of Zinc Finger Proteins on Various Repetitive Elements. The analysis of 
ENCODE ChIP data sets showed that ZNF146 and ZNF507 (black circle) have much stronger enrichment 
levels on L1 elements compared to 153 other ZNFs. The two proteins also showed no similar enrichment 
level across nine other common repetitive elements.  
 
 
 Further refinement of the ZNF146 and ZNF507 enrichment peaks (Figure 9) was 
performed to determine which types of repetitive elements the ZNFs bind.  The data showed that 
81% of ZNF146 peaks occurred in annotated L1 sequences, while 78% of the repetitive elements 
bound to ZNF507 peaks were in L1 sequences.  ZNF146 had roughly 37,000 ChIP peaks on L1, 
while ZNF507 had roughly 12,000 (Figure 9). However curiously, despite being enriched on the 
same element, only 116 of the peaks for the two ZNF proteins overlapped. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. ChIP Enrichment Binding of ZNF146 and ZNF507 to Various Repetitive 
Elements.   Note that 81% of the repetitive elements bound to ZNF146 were to L1, while 
78% of the elements bound to ZNF507 were to L1. Overlap of the two analyses occurred 
in only 116 of the 48,712 identified peaks.  
 35 
 
 
 The enrichment peaks for the two ZNF proteins on L1 were then further analyzed to 
identify the potential binding sites on the repetitive elements. ZNF146 enrichment peaks strongly 
localized to the 3’ end of L1 ORF2 (blue in the diagram), while ZNF507 enrichment peaks (red 
in diagram) localized to the 5’ end of L1 ORF2 (Figure 10). Homer prediction software was then 
used to construct a binding consensus for each ZNF (Figure 10). The binding consensus for the 
most recent subfamily of L1 elements were found to be GAATACTATGCAG and 
TAAATATAAATG, for ZNF146 and ZNF507, respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10.  Potential Binding Site Locations of ZNF146 and ZNF507 on L1 DNA 
Elements.  Shown is the ChIP enrichment data for ZNF146 and ZNF507 for the ORF2 of 
the most recent subfamily of L1 DNA elements.  
 
 
Evolutionary Conservation of the Predicted Binding Domains 
 
The conservation of the predicted binding regions for the two ZNF proteins on L1 
sequences was characterized through a clustal alignment of the L1 subfamily sequences.  The 
analysis included an area approximately 10nt surrounding the predicted binding motif. These 
domains were imported into Jalview to generate a conservation score and arrange the subfamilies 
by age. The conservation of ZNF-binding sequences was determined for several L1 DNA 
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families, whose nomenclature is as follows: PA denotes primate-specific L1 sequences, and MA 
denotes mammalian.   PA L1 sequences diverged from mammalian L1’s at MA6.  MA 
sequences, however, continued to evolve within the human genome.  The sequences are also 
divided into sub-families.  Evolutionarily the youngest (most recent) L1 sub-families have the 
lowest numbers, so L1 PA1 denotes modern human L1, and PA4 is an older sub-family.  The 
oldest sequences L1 sub-families within the human genome are named in descending order, with 
MA being the youngest, and ME being the oldest. Due to a 5’ truncation, the L1 sub-families are 
divided into two categories based on which end of the sequence was analyzed. However, these 
sequences are synonymous with one another, so 5’ L1 P1 is equivalent to 3’ L1 PA2-PA3 
(Figure 4).  
The binding region of ZNF146 (Figure 11) was found to be highly conserved for primate 
L1 subfamilies, only encountering a T-C substitution at PA15. A comparison of primate to 
mammalian L1 revealed a prevalent G-C substitution in primates within the binding motif when 
compared to present mammals, among several other substitutions (Figure 11). Furthermore, the 
area surrounding the predicted binding motif showed similar high levels of conservation across 
both primate and mammalian sub-families.  
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Figure 11. Conservation of the Predicted Binding Regions for ZNF146 Across L1 Subfamilies.  DNA 
sequences within 10 bp surrounding the predicted ZNF146-binding motifs of various L1elements were 
analyzed for conservation using a clustal alignment.  These domains were imported into Jalview to generate 
a conservation score and arrange the subfamilies by age.  The sequences represent, from top to bottom:  
L1PAs (primate specific L1 subfamilies, including human), L1Mas (mammalian specific L1 subfamilies, 
including human), L1MM (youngest mouse L1 subfamily.  The colors denote specific nucleic acids: red 
(guanine), yellow (cytosine), blue (thymine), and green (adenine). Marked in red above the alignment and 
below the conservation scores is the predicted ZNF binding motif. 
 
 
The data for the conservation of the binding region for ZNF507 (Figure 12) shows an A-
to-G substitution in primates at the P4 and PA13-17 sub-families.  Interestingly, the youngest 
subfamily PA1, showed a specific G-A substitution in the middle of a palendromic stretch of the 
sequence. Apart from these differences, the predicted binding motif was found to be highly 
conserved across all primate subfamilies tested, but was less conserved between mammalian and 
primate subfamilies. 
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Figure 12. Conservation of the Predicted Binding Regions for ZNF507 Across L1 Subfamilies.  DNA 
sequences within approximately 10 bp surrounding the predicted ZNF507-binding motifs of various L1 
subfamilies were analyzed for conservation using a clustal alignment.  These domains were imported into 
Jalview to generate a conservation score and arrange the subfamilies by age. Due to a truncation the 
nomenclature is altered from the previous ZNF146 figure as follows: P1 is equivalent to PA2-PA3; P2 is 
equivalent to PA4-PA6, and so on as illustrated in Figure 4. The sequence codes are as indicated in the 
previous figure, except for the following: n (any nucleotide), r (adenine or guanine), and m (cytosine or 
adenine). 
 
 
 A second alignment of the predicted binding regions for the two ZNFs on L1 across 
several species using the same programs implemented previously (Figure 13) revealed similar 
data: a high conservation of the ZNF146 and ZNF507-binding sequences, and lower levels of 
conservation flanking the binding sequences.  The blue bars within these figures denote the 
predicted binding regions of the ZNFs on L1 as predicted by the Princeton software as of 
December 2017.
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Figure 13.  A Second Analysis of the Species Conservation of the Predicted Binding Regions 
for ZNF146 and ZNF507 on L1 Sequences.  The alignment was performed as described in the 
previous figure, and the sequence codes are the same except for the following: the blue bar above 
the sequences denotes a predicted binding site found by the Princeton program, and the black bar 
denotes the oligo used during our pull-down procedures. 
 
 
 
Evolutionary Conservation of the Zinc Finger Domain Sequences 
 
 The zinc finger domain sequences of both ZNF146 and ZNF507 were predicted using 
Princeton prediction software, and aligned in the same manner as the previous figures to examine 
the evolutionary conservation of the binding regions of the proteins. The various species selected 
for the alignment contained both ZNF146 and ZNF507 amino acid sequence data. The 
phylogenetic trees shown to the left of each figure panel denote the general evolutionary 
divergence of the ZNF proteins between the species. The zinc finger sequences for ZNF146  
(Figure 14) were found to be completely conserved in 7 out of 10 zinc fingers, with 2 showing 
only a single amino acid substitution in a single species.  All the substitutions were within the 
same class of amino acids. 
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Figure 14.  Alignment of the Zinc Finger Sequences of ZNF146 Across Mammals. 
 
The alignment for ZNF507 zinc fingers (Figure 15) showed less conservation. While 
most amino acid substitutions were within the same amino acid group, two of the fingers showed 
species-specific substitutions that were not within the same group of amino acids. The second 
zinc finger of ZNF507 had an E (Glu) (charged) to Q (Gln) (neutral) substitution in mice and 
rats. However, primates showed a different N (Asn) to H (His) substitution in the fifth zinc finger 
that was highly conserved and was not seen in any other species tested (Figure 15).  
 
 
 
Figure 15. Alignment of the Zinc Finger Sequences of ZNF507 Across Mammals. 
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Present-Day Conservation of L1 ZNF Binding Sites Using ChIP-Seq Enrichment  
 
 The conservation of ZNF 146 and 507 binding retentions was analyzed across several 
present-day L1 subfamilies through ChIP-seq dataset mapping. ZNF146 was found to have 
conserved binding locations across all L1 primate subfamilies (Figure 16, top panels). The 
reduced binding signal observed for subfamily PA1-PA4 likely resulted from the low unique 
mapability of these L1 subfamily sequences (Figure 16, bottom panels). On the other hand, the 
L1 binding capacity for ZNF507 was lost from subfamily P4/PA10 onward (Figure 17). This 
loss was also seen in the nucleotide alignments as the A-T nucleotide substitution in the binding 
motif (Figure 12). Thus, this substitution may contribute to ZNF507 acquiring the ability to bind 
L1 repeats. 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 16. Present-Day Conservation of L1 Binding Sites for ZNF146 Using ChIP-Seq Enrichment. 
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Figure 17.  Present-Day Conservation of L1 Binding Sites for ZNF507 Using ChIP-Seq Enrichment. 
 
 
 
Verification of ZNF Binding Sites Using Antibody Pull-Down Assays with Biotinylated 
DNA Oligos 
 
 The binding of ZNF146 and ZNF507 to their respective binding consensus was verified 
biochemically using pull-down assays (Figure 18).  Biotinylated DNA oligos representing each 
binding consensus were mixed with HeLa cell nuclear lysates containing ZNFs. Biotinylated 
oligo-ZNF complexes were purified by ZNF-binding precipitations using oligo bound beads 
containing the specific binding site for each ZNF. Then the intensity of the ZNF protein 
concentration was assessed by a western blot using antibodies against the specific ZNFs.  When 
ZNF proteins were purified using the predicted binding site oligos bound to beads, the pulldown 
of ZNF146 showed a strong pulldown efficiency.  In the same sample, a much weaker signal was 
observed when pulling-down with the ZNF507 binding consensus, and no signal was observed 
for the ZNF507-purified sample. Lowering the salinity or adding Zn2+ into the washes yielded 
similar results (data not shown). Thus, ZNF146 was able to bind the predicted ZNF146 
 43 
consensus.  No signals were observed for the sample immuno-precipitated with the ZNF507 
antibody, so the binding of ZNF507 to its consensus has not been validated.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18.  Biochemical Verification of the Binding of ZNF146 to its Predicted L1 Consensus.  
Biotinylated DNA oligos representing the predicted ZNF146 and ZNF507 binding sites were mixed with 
nuclear lysates containing ZNFs, and the samples were immuno-precipitated using streptavidin coated 
beads bound to oligos containing for either the ZNF146 (upper panel) or ZNF507(lower panel) binding 
motif.  The samples were electrophoresed, blotted to membrane, and the signal of biotinylated oligo 
determined by exposure to a secondary antibody to ZN146 or ZNF507.  Lanes denote the type of 
biotinylated oligo used in each pulldown.  Poly TA was used as a negative control. Further testing was 
done using flag-tagged ZNF transfections, which were assessed using mouse anti-flag and anti-mouse 
HRP antibodies. Alterations in the salinity content and adding Zn2+ during washes yielded identical 
results.  Antibody designations on the right denote the antibody used for detection of ZNF146 or 
ZNF507 in the western blot of purified samples. 
 
 
Cellular Localization of ZNF146 and ZNF507 
 
The cellular locations of ZNF146 and ZNF507 were determined by immunofluorescence 
microscopy (IF) on Flag-tagged ZNFs.  HeLa cells were transfected with plasmids encoding 
Flag-tagged ZNFs, and IF was performed at 48-hours post-transfection using anti-Flag antibodies 
(Figure 19).  The data showed that both ZNF146 and ZNF407 localized to the nucleus in HeLa 
cells, as expected for DNA binding proteins.  The ZNF proteins were excluded from the 
nucleolus. Slight cytoplasmic localization was also observed in ZNF507 transfected cells. These 
findings were confirmed in both HEK293 and TIG-1 cells (data not shown).  
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Figure 19. Cellular Localization of ZNF146 and ZNF507.  The locations of flag-tagged 
ZNFs 146 and 507 in transfected HeLa cells were detected using anti-flag antibodies. Both 
ZNFs show a nuclear localization, and nucleolar exclusion, as expected for DNA-binding 
proteins. Green denotes flag-tag signal (ZNF146 or ZNF507), blue denotes DAPI staining 
for nuclear morphology.  
 
 
We noticed that some of the transfected HeLa cells showed signs of toxicity, so this was 
tested further (Figure 20).  Stable flag-tagged ZNF over-expression lines were generated, but 
after a 3-week period only a few HeLa cells expressing the flag-tagged ZNF proteins remained 
(Figure 20), suggesting a selection against cells over-expressing these ZNFs. The few cells that 
still over-expressed the ZNFs at 3-weeks (as tested by IF) showed a very unhealthy nuclear 
morphology. Thus, over-expression of the ZNFs long-term may have a deleterious effect on 
HeLa cells. 
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Figure 20. Deleterious Effects of Over-Expression of ZNF146 or 
ZNF507 in HeLa Cells for 3-Weeks. Cells were transduced with 
plasmids expressing flag-tagged ZNFs, and were selected over a 3-
week period to determine if stable integration was possible and to 
examine the effect of long-term ZNF over-expression. Green and 
blue denote flag-tagged ZNFs or nuclei, respectively. 
 
 
Over-Expression of ZNFs in HEK293 Show Possible Cell Phase Arrest 
 
Transfection of the ZNF expression plasmids into HEK293 cells (Figure 21) showed 
nuclei that appear to be enlarged relative to non-transfected cells.  This phenotype may result 
from blockage at the G2 cell phase, so Ki-67 IFA staining was performed (Figure 21). This 
analysis showed that the ZNFs (detected by flag antibody, green), were found exclusively in Ki-
67 G2 cells. These results suggest that over-expression of the ZNFs could result in cell phase 
arrest at G2, thereby causing the ZNF-containing cells to be outcompeted, as seen in the long 
term HeLa cell transfections. 
 
 
 
 
 
 
  
Figure 21. Microscopy of HEK293 Cells Over-Expressing ZNF 146 or ZNF507.  Cells 
were transfected for 48-hours with plasmids encoding flag-tagged  ZNF146 or 507, fixed 
onto coverslips, and incubated with antibodies to detect flag-tag (green), Ki-67 (red), or 
DAPI (blue). 
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Effect of ZNF Knockdown in HEK Cells 
 
The potential effects of lowering the expression of ZNF146 and ZNF507 in HEK293 
cells were studied using knockdowns induced by sh-RNA expressing plasmids (Figure 22).  
Although we have not yet verified a lowering of the ZNF signal in these sh-plasmid-treated cells, 
the data showed that knockdown of either ZNF protein appears to cause two distinct types of cell 
senescence. The nuclei of HEK293 cells treated with ZNF146 sh-plasmid appeared to have 
significantly enlarged nuclei and a severely weakened DAPI signal (Figure 22). Additional 
detection by laminin B antibody revealed that the nuclear boundary shown by DAPI staining was 
indeed accurate. The cytoplasm also appears to have enlarged as seen by tubulin detection 
(Figure 22). This phenotype is indicative of induced cell senescence (Leontieva et al., 2011; 
Micco et al., 2011). 
On the other hand, knockdown of ZNF507 appeared to result in a different type of cell 
senescence. In this case, the nuclei retained a relatively normal size and shape, but the DAPI 
detection took on a dotted, almost speckled appearance, known as compacted punctate DAPI 
(Figure 22). Punctuated DAPI appearance is known to commonly occur in senescent cells 
(Zhang et al., 2007). 
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Figure 22. Microscopy of HEK Cells Treated with ZNF sh-Plasmids to Lower ZNF 
Expression.  Cells were transfected for 48-hours, fixed onto coverslips, and then 
incubated with antibodies to detect the following: blue (DAPI), green (tubulin), red 
(laminin-B). 
 
 
Identification of ZNF-Associated Proteins 
 
As discussed in the Background, ZNF proteins often bind other proteins that regulate 
gene expression.  In these cases, the ZNF confers DNA-binding ability to the regulator.  In order 
to identify proteins that interact with ZNF146 and ZNF507 (and that could affect L1 gene 
expression), HEK293 cells over-expressing flag-tagged ZNF146 or ZNF507 were lysed, and the 
ZNF and any associated proteins were purified by immunoprecipitation (IP) with anti-flag 
antibody (Figure 23).  The initial IP experiment (Figure 23A) confirmed that flag-tagged 
ZNF507 could in fact be purified from a nuclear extract. The subsequent IP (Figure 23B) 
showed that flag-tagged ZNF146 and ZNF507 could be isolated. 
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Figure 23. Immunoprecipitation of Flag-tagged ZNF507 and Associated Proteins. HEK293 cells were 
transfected with plasmid encoding flag-tagged ZNF507 or 146, lysed, and then nuclear extracts were 
prepared. Nuclear extracts were immuno-precipitated with anti-flag antibody to pull down ZNF507 or 
ZNF146 and any associated proteins. A) The initial IP experiment analyzed the ZNF507 IP sample relative to 
input sample to confirm successful purification compared to input. B) Analysis of the ZNF507 and ZNF146 
IP samples to verify successful purification of the ZNFs. 
 
 
Potential ZNF-interacting proteins were identified from the purified IP samples using 
mass spectrometry (Figure 24).  Purified IP samples were briefly run through a gel, stained, cut 
out, and then sent for mass spectrometry analysis at UMMS. The amount of protein isolated from 
the ZNF146 sample (middle lane in the figure) was insufficient for analysis, but the ZNF507 IP 
sample (right lane) contained a robust ZNF507 band and faint other lower MW bands (Figure 
24). Mass spectrometry results of the ZNF507 IP sample (Table 1) revealed several proteins 
with gene regulatory function, including PRMT5, PPM1B, WDR77, and two RBBP proteins. 
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Figure 24.  Isolation of Protein Present in the ZNF507 IP Sample 
Sent for Mass Spec Analysis. The over-expressed ZNF507 band 
(red circle) was the most prevalent band in the 507 IP sample (right 
lane), and other lower-MW proteins are also present. The middle lane 
between the ladder and ZNF507 shows the ZNF146 IP sample, with a 
faint protein band near the bottom of the gel likely representing 146. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1. Mass Spec Analysis of the ZNF507 IP 
Sample. The list shows proteins identified by mass 
spec analysis of the ZNF507-IP sample.  Shown 
in yellow is ZNF507, and in green are several 
regulatory proteins of interest. 
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DISCUSSION 
 
 
 Non-coding DNA sequence elements make up roughly 98% of the human genome.  
LINE-1 (L1) repetitive elements are currently thought to make up 17.5% of the genome, 
excluding those found in intronic sequences. Despite comprising such a large proportion of the 
genome, the function and regulation of L1 elements remains unknown. Studies have shown that 
L1 expression induces retrotransposition and can be toxic to cells.  L1 ORF2 contains the main 
machinery for retro-transposition. Due to the innate danger that large-scale L1 transposition 
would have on nearby genes, this process is normally strongly repressed in somatic cells. 
However, L1 elements sometimes escape repression, giving rise to new L1 subfamilies that 
require new a means of repression. This cycle of L1 expression, retrotransposition, and silencing 
can be thought of an evolutionary arms race between the emergence of new L1 subfamilies and 
the adaptation of new repressive machinery.  
Zinc finger proteins (ZNFs) bind DNA, and their direct binding to regulatory proteins 
confers sequence-specific recruitment to DNA.  This MQP project investigated whether ZNFs 
bound to L1 elements might provide a mechanism for L1 repression or activation.  A 
bioinformatics approach showed that ZNF146 and ZNF507 proteins potentially have strong 
binding affinity to L1 elements at opposite ends of ORF2, and this binding was verified by oligo 
pull-down assays.  The ZNF146 and ZNF507 protein zinc finger sequences and the L1 binding 
regions showed strong evolutionary conservation. Furthermore, ZNF binding across L1 
subfamilies was also found to be strongly retained for ZNF146.  On the other hand, ZNF507 
showed a specific period of binding loss past a certain subfamily age that appeared to be linked 
to a specific point mutation in the predicted L1 binding region.  Immunoprecipitation of 
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ZNF507-protein complexes followed by Mass spectrometry identified several ZNF507 
interacting regulatory proteins (purple in the figure) that potentially use ZNF507 as a guide for 
targeted L1 repression (Figure 24). PRMT5, the protein found with the highest peptide count, is 
a histone arginine methyltransferase.  Histone arginine methylation is often associated with gene 
repression (Girardot et al., 2014; Litt et al., 2009).  
 
 
 
Figure 24. Theorized Mechanism of L1 Element Repression Through ZNF Associated Regulatory 
Proteins. The diagram shows the L1 DNA element and its two associated ORFs.  In this MQP project, 
bioinformatics and biochemical analyses identified two ZNFs (146 and 507) that bind to opposite sides of 
ORF2 (red and blue).  Immunoprecipitation assays identified regulatory proteins, such as PRMT5 (purple) 
(and others), that associate with ZNF507, that could theoretically alter expression of the L1 element. 
 
 The effects of over-expression and under-expression of the two ZNFs was also studied. 
Over-expression of either of the two ZNF proteins appeared to be toxic to cells.  Such cells 
displayed Ki-67 patterns seen only in the G2 cell phase (Figure 21) (Solovjeva et al., 2012), so 
these cells may be arrested in the G2 phase due to ZNF over-expression. If the two ZNF proteins 
in fact bind strongly to L1, which constitutes 17.5% of the human genome, the binding of the 
overexpressed proteins to additional targets may mis-regulate the genome or specific cell cycle 
genes. Under-expression on the other hand led to DAPI stain patterns typical of cells in 
senescence (Figure 22) (Micco et al., 2011). Given that expression of the L1 ORF2 alone has 
been shown to induce cell senescence, this finding suggests that the ZNFs may help silence L1 
ORF2, and the ZNF knockdown allowed ORF2 expression. 
 52 
 These studies would have benefitted from validation of ORF2 expression levels under 
different ZNF expression conditions. Unfortunately, as of the writing of this report, the only 
commercially available antibody against ORF2 showed no signal, even when tested against a cell 
line over-expressing ORF2. Because L1 has approximately 950,000 fragments in the genome, 
assays such as Northern blots or RT-PCR would have yielded too many false positives to be 
conclusive. Without a confident means for accurately detecting full length L1 or ORF2 
transcription, a direct correlation between the presence of the two ZNF proteins and a lowered 
L1 gene expression could not be established. Future studies would hope to characterize an 
indirect correlation between ZNF 146 and 507 levels and L1 transcription.   
We have verified a specific binding of ZNF146 to the predicted L1 DNA consensus 
domain in vitro. The unsuccessful oligo pulldown of the ZNF507 binding site was likely 
hindered by our lack of knowledge of the ZNF507 tertiary structure. The predicted binding motif 
was found by analyzing its strong stretch of five consecutive zinc fingers, while the other non-
contiguous zinc fingers are separated further away on the protein and could play a role in further 
binding upstream on L1. The lack of inclusion of this upstream consensus sequence in our 
biotinylated oligo could have resulted in unsuccessful ZNF507 pulldown. Alternatively, a key 
cofactor could have been lost which was required for ZNF507 binding. 
With respect to the Mass spec analysis of ZNF-associated proteins, the approach worked 
well with ZNF507 (to identify regulatory protein PRMT5), but not with ZNF146.  This may 
simply have resulted from an insufficient amount of protein in the ZNF146 IP sample, possibly 
due to elevated cell toxicity, so this could be repeated using larger amounts of input material or 
using optimized conditions. If some of the ZNF146-binding proteins are found to be regulatory 
in nature, combined with the findings documented in this report, this would support the theory 
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that both ZNF146 and ZNF507 play a role in L1 repression in somatic cells. Very few proteins 
have been identified as binding to transposable elements and regulating their expression.  This 
MQP study goes a long way towards characterizing two ZNF proteins with relatively no known 
function as L1 regulatory proteins. These proteins have been implicated as misregulated in 
cancer and neurological disorders, and these findings may impact the understanding of disease.
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